Section one: Contracting authority
one.1) Name and addresses
University of Exeter
Northcote House
Exeter
EX4 4QH
Contact
Megan Brine
Telephone
+44 1392723333
Country
United Kingdom
Region code
UKK - South West (England)
National registration number
RC000653
Internet address(es)
Main address
Buyer's address
https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/53042
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=69067&B=EXETER
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=69067&B=EXETER
Tenders or requests to participate must be submitted to the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Education
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Whole genome sequencing services
Reference number
UOE/2023/029/MB
two.1.2) Main CPV code
- 73000000 - Research and development services and related consultancy services
two.1.3) Type of contract
Services
two.1.4) Short description
Provision of whole genome sequencing services.
two.1.5) Estimated total value
Value excluding VAT: £250,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 73000000 - Research and development services and related consultancy services
two.2.3) Place of performance
NUTS codes
- UKK - South West (England)
two.2.4) Description of the procurement
A team of academics from the University of Exeter (Faculty of Health and Life Sciences) have funding from Diabetes UK and the Wellcome Trust to perform whole genome sequencing on patients with early-onset/neonatal diabetes, syndromic diabetes and Hyperinsulinism.
The aim of this work is to identify mutations in novel genes and non-coding regions causing these diseases.
The University of Exeter intends to award a contract to a single supplier for 12-months, with the option to extend by 3 further 12-month periods, to provide human whole genome sequencing services to at least 30X average coverage. It is highly desirable that these services use either of the University’s preferred sequencing technology: Illumina or BGI sequencing. This is due to the established bioinformatics and analysis pipelines using these technologies.
These samples are from our Genetic Beta-Cell biobank of patients with suspected monogenic forms of diabetes or hyperinsulinism. Bidders using alternative technology may submit a bid, however, must be able to provide the University with assurance that equivalent results/data will be produced.
Via this funding route, the University expects to be able to provide between 100 and 200 samples per annum, to be sent to the supplier in batches throughout a 12-month period. The average number of samples submitted per annum for sequencing over the previous 5-year period is 131, however, please note that these figures are provided for indicative purposes only and are subject to increase/decrease dependent on research requirements.
A second funding application has been submitted to increase the scale of the above research. If this is successful, the University may require whole genome sequencing services for a further 1824 samples over a two-year period. However, this is subject to the application being successful and the University can make no commitment to these volumes.
Our full technical requirements can be found in document ‘UOE.2023.029.MB – Technical Specification and Pricing Schedule’.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £250,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
12
This contract is subject to renewal
Yes
Description of renewals
The University includes the option to extend this contract for three (3) further twelve (12) month periods.
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
4 July 2023
Local time
12:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 6 (from the date stated for receipt of tender)
four.2.7) Conditions for opening of tenders
Date
4 July 2023
Local time
12:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
Royal Court of Justice
Strand
London
WC2A 2LL
Country
United Kingdom
six.4.2) Body responsible for mediation procedures
Royal Court of Justice
Strand
London
WC2A 2LL
Country
United Kingdom
six.4.4) Service from which information about the review procedure may be obtained
Royal Court of Justice
Strand
London
WC2A 2LL
Country
United Kingdom